| Date Filed | Type | Description |
| 10/11/2023 |
8-K
| Quarterly results |
| 10/11/2023 |
424B5
| Form 424B5 - Prospectus [Rule 424(b)(5)]: |
| 08/17/2023 |
25-NSE
| Form 25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities: |
| 08/14/2023 |
8-K
| Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements... |
| 08/09/2023 |
10-Q
| Quarterly Report for the period ended June 30, 2023 |
| 08/09/2023 |
8-K
| Quarterly results |
| 08/04/2023 |
8-K
| Material Modifications to Rights of Security Holders, Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Yea... |
| 07/07/2023 |
SC 13G/A
| BlackRock Inc. reports a 2% stake in Bionano Genomics, Inc |
| 06/16/2023 |
4
| Mamuszka Hannah (Director) has filed a Form 4 on Bionano Genomics, Inc.|
Txns:
| Granted 250,000 options to buy
@ $0.7458, valued at
$186.5k
|
|
| 06/16/2023 |
4
| Rajkovic Aleksandar (Director) has filed a Form 4 on Bionano Genomics, Inc.|
Txns:
| Granted 250,000 options to buy
@ $0.7458, valued at
$186.5k
|
|
| 06/16/2023 |
4
| Luderer Albert (Director) has filed a Form 4 on Bionano Genomics, Inc.|
Txns:
| Granted 250,000 options to buy
@ $0.7458, valued at
$186.5k
|
|
| 06/16/2023 |
4
| Linney Yvonne (Director) has filed a Form 4 on Bionano Genomics, Inc.|
Txns:
| Granted 250,000 options to buy
@ $0.7458, valued at
$186.5k
|
|
| 06/16/2023 |
8-K
| Submission of Matters to a Vote of Security Holders Interactive Data |
| 06/16/2023 |
4
| Wong Vincent Jung-Fai (Director) has filed a Form 4 on Bionano Genomics, Inc.|
Txns:
| Granted 250,000 options to buy
@ $0.7458, valued at
$186.5k
|
|
| 06/16/2023 |
4
| Vuori Kristiina MD (Director) has filed a Form 4 on Bionano Genomics, Inc.|
Txns:
| Granted 250,000 options to buy
@ $0.7458, valued at
$186.5k
|
|
| 06/16/2023 |
4
| TWOMEY CHRISTOPHER J (Director) has filed a Form 4 on Bionano Genomics, Inc.|
Txns:
| Granted 250,000 options to buy
@ $0.7458, valued at
$186.5k
|
|
| 06/16/2023 |
4
| BARKER DAVID L (Director) has filed a Form 4 on Bionano Genomics, Inc.|
Txns:
| Granted 250,000 options to buy
@ $0.7458, valued at
$186.5k
|
|
| 05/16/2023 |
4
| Holmlin R. Erik (President and CEO) has filed a Form 4 on Bionano Genomics, Inc.|
Txns:
| Bought 15,000 shares
@ $0.6426, valued at
$9.6k
|
|
| 05/16/2023 |
4
| Stewart Christopher P. (CFO) has filed a Form 4 on Bionano Genomics, Inc.|
Txns:
| Bought 50,000 shares
@ $0.6683, valued at
$33.4k
|
|
| 05/16/2023 |
4
| OLDAKOWSKI MARK (COO) has filed a Form 4 on Bionano Genomics, Inc.|
Txns:
| Paid exercise price by delivering 41,496 shares
@ $0.66, valued at
$27.4k
|
|
| 05/16/2023 |
4
| Holmlin R. Erik (President and CEO) has filed a Form 4 on Bionano Genomics, Inc.|
Txns:
| Paid exercise price by delivering 50,141 shares
@ $0.66, valued at
$33.1k
|
|
| 05/11/2023 |
EFFECT
| Form EFFECT - Notice of Effectiveness: |
| 05/09/2023 |
10-Q
| Quarterly Report for the period ended March 31, 2023 |
| 05/09/2023 |
8-K
| Quarterly results |
| 05/08/2023 |
S-3/A
| Form S-3/A - Registration statement under Securities Act of 1933: [Amend] |
| 05/01/2023 |
DEFA14A
| Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material: |
| 04/28/2023 |
DEFA14A
| Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material: |
| 04/28/2023 |
DEF 14A
| Form DEF 14A - Other definitive proxy statements: |
| 04/24/2023 |
8-K
| Quarterly results |
| 04/14/2023 |
PRE 14A
| Form PRE 14A - Other preliminary proxy statements: |
| 04/14/2023 |
8-K
| Quarterly results |
| 03/13/2023 |
8-K
| Other Events Interactive Data |
| 03/10/2023 |
S-3
| Form S-3 - Registration statement under Securities Act of 1933: |
| 03/09/2023 |
S-8
| Form S-8 - Securities to be offered to employees in employee benefit plans: |
|